Diabetes is a disease that affects over 16 million people in the USA at a cost of 100 billion dollars annually. The ability to regulate insulin delivery in people with Type 1 diabetes is imperative as is the need to manage glucose levels in all people with this disease. Our current method for monitoring glucose is a (FDA approved) minimally invasive enzymatic sensor that can measure glucose levels in vivo for three days. We are focused on developing a noninvasive implantable glucose sensor that will be interrogated by an external device. The material must be robust, easy to process, biocompatible and resistant to biofouling. In this Presentation we will discuss the development of a new polymeric matrix that can recognize physiological levels of glucose in vitro using fluorescent spectroscopy.

The formation of dibaryons with strangeness are discussed for the interior of neutron stars and for central relativistic heavy-ion collisions. We derive limits for the properties of H-dibaryons from pulsar data. Signals for the formation of possible bound states with hyperons at BNL's Relativistic Heavy-Ion Collider (RHIC) are investigated by studying their weak decay patterns and production rates.